Detalhe da pesquisa
1.
Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trial.
J Am Acad Dermatol
; 90(6): 1232-1239, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38266683
2.
Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind study.
J Am Acad Dermatol
; 83(1): 96-103, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32032692
3.
Pharmacokinetics and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study.
J Am Acad Dermatol
; 82(2): 389-397, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31408686
4.
Qualitative analysis and reproducibility assessment of the Scalp Itch Numeric Rating Scale among patients with moderate to severe plaque psoriasis of the scalp.
J Dermatolog Treat
; 30(8): 775-783, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30747550